Peer-reviewedCC BY-NC 4.0Cancer Biology & Medicine
Rethinking nasopharyngeal carcinoma management: toward a low-toxicity, highly effective regimen with favorable tolerability and quality of life
- 1Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China
- 2Sun Yat-sen University School of Medicine, Sun Yat-sen University, Shenzhen 518000, China
- 3Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
Related
- A Delphi consensus recommendations from China for the management of radiation-induced hearing loss in patients with nasopharyngeal carcinoma.
- Primary Epstein–Barr virus-negative lymphoepithelioma-like carcinoma of the supraglottic larynx mimicking nasopharyngeal carcinoma: a case report
- The association between serum uric acid and prognosis of nasopharyngeal carcinoma: a comprehensive meta-analysis of observational studies
- Nasopharyngeal Carcinoma Mimicking Juvenile Nasopharyngeal Angiofibroma in an Adolescent Ghanaian Male: A Diagnostic Pitfall.
- Epstein-Barr virus co-opts ADAR1 to evade PKR activation of the integrated stress response in nasopharyngeal carcinoma
BibTeX
@article{zhang2026rethinking,
title = {{Rethinking nasopharyngeal carcinoma management: toward a low-toxicity, highly effective regimen with favorable tolerability and quality of life}},
author = {Yingni Zhang and Chunxian Ou and Cheng Xu},
journal = {Cancer Biology \& Medicine},
year = {2026},
month = aug,
doi = {10.20892/j.issn.2095-3941.2026.0316},
url = {https://doi.org/10.20892/j.issn.2095-3941.2026.0316},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Rethinking nasopharyngeal carcinoma management: toward a low-toxicity, highly effective regimen with favorable tolerability and quality of life
AU - Yingni Zhang
AU - Chunxian Ou
AU - Cheng Xu
PY - 2026
DA - 2026/08/08
JO - Cancer Biology & Medicine
DO - 10.20892/j.issn.2095-3941.2026.0316
UR - https://doi.org/10.20892/j.issn.2095-3941.2026.0316
SN - 2095-3941
ER -